| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |